The presence of microvascular invasion guides treatment strategy in recurrent HBV-related HCC

ConclusionsMVI status definitely helps select treatment options in HBV+ rHCC patients. For MVI( −) patients, RR/RFA provided better survival than TACE while for MVI(+) patients, TACE shared similar survival outcomes.Key Points• This study aimed at the determination of the optimal treatment options (ablation /resection vs TACE) in case of recurrent HBV-related HCC.• It showed that MVI status, established at primary resection of HCC, was a powerful marker for selecting the best treatment option in these patients.• In MVI(−) patients, RR/RFA achieved a better survival than TACE. In MVI(+) patients, TACE shared similar survival.
Source: European Radiology - Category: Radiology Source Type: research